Existing data demonstrate that pro-BDNF, BDNF and TrkB-FL levels are reduced in the brain of AD patients, while TrkB-Tc are increased (Connor et al., 1997; Ferrer et al., 1999; Michalski and Fahnestock, 2003). The gene discussed is BDNF; the disease is Alzheimer disease.